An anchoring molecule increases intravitreal retention of antibody-based therapeutics used in the treatment of ocular diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An anchoring molecule increases intravitreal retention of antibody-based therapeutics used in the treatment of ocular diseases

Published:2020-12 Issue: Volume:328 Page:263-275
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Gao Quanqing,Schachar Ira H.

Funder

Research to Prevent Blindness

National Eye Institute

Stanford University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference57 articles.

1. Vascular endothelial growth factor a in intraocular vascular disease;Miller;Ophthalmology.,2013

2. Intravitreal Aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study;Clark;Ophthalmology,2016

3. Jaffe, Ranibizumab and bevacizumab for neovascular age-related macular degeneration;CATT Research Group;N. Engl. J. Med.,2011

4. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial;Wells;Ophthalmology.,2016

5. Rituximab for intraocular lymphoma;Itty;Retina.,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond;Advanced Drug Delivery Reviews;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP